Noh, H., Cho, H., & Joung, J. (2026). Efficacy and safety of nafamostat mesilate in pediatric continuous renal replacement therapy: A 5-year retrospective study in South Korea. Childhood Kidney Diseases, 30(2), 143. https://doi.org/10.3339/ckd.26.011
Chicago Style (17th ed.) CitationNoh, Hyunseung, Heeyeon Cho, and Jinwoon Joung. "Efficacy and Safety of Nafamostat Mesilate in Pediatric Continuous Renal Replacement Therapy: A 5-year Retrospective Study in South Korea." Childhood Kidney Diseases 30, no. 2 (2026): 143. https://doi.org/10.3339/ckd.26.011.
MLA (9th ed.) CitationNoh, Hyunseung, et al. "Efficacy and Safety of Nafamostat Mesilate in Pediatric Continuous Renal Replacement Therapy: A 5-year Retrospective Study in South Korea." Childhood Kidney Diseases, vol. 30, no. 2, 2026, p. 143, https://doi.org/10.3339/ckd.26.011.